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Autoimmunity to Gephyrin Case Study
in Stiff-Man Syndrome
may express neuronal antigens and that in some pa-
tients, an immune response directed against these anti-
gens spreads to the nervous system, thus inducing neu-
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rological symptoms (Anderson et al., 1987).Pietro De Camilli,1,2,7 and Michele Solimena2,3,7
SMS (also known as Stiff-Person syndrome) is an ac-1Howard Hughes Medical Institute
quired rare disorder of the CNS characterized by rigidity2Department of Cell Biology
and spasms of the body musculature (Moersch and3Department of Internal Medicine
Woltman, 1956; Lorish et al., 1989; Blum and Jankovic,Yale University School of Medicine
1991; Stayer and Meinck, 1998). The disease resemblesNew Haven, Connecticut 06510
a chronic form of tetanus and affects mostly women.4Department of Anatomy and Neurobiology
Clinical and pharmacological evidence suggests thatWashington University School of Medicine
SMS results from an impairment of inhibitory pathwaysSt. Louis, Missouri 63110
that control the activity of motoneurons in the brainstem5Institute for Biochemistry
and spinal cord (Meinck et al., 1984; Floeter et al., 1998).University of Erlangen-Nuremberg
Electromyography shows a persistent motoneuron ac-Erlangen D-91054
tivity that is indistinguishable from voluntary muscle ac-Germany
tivity, except that the patients are not able to relax. Most6Department of Neurology
patients respond to high doses of drugs that enhanceInstitute of Clinical Medicine
the action of GABA, such as benzodiazepines, baclofen,University of Tsukuba
or sodium valproate. These treatments, however, do1-1-1 Tennoudai
not affect the slowly progressive course of the disease.Tsukuba 305-8575
Patients are eventually bedridden, and respiratory fail-Japan
ure or sudden death may occur (Mitsumoto et al., 1991).
In the majority of cases, an autoimmune pathogenesis
appears likely (Solimena and De Camilli, 1991).
More than 60% of patients with SMS have high titerSummary
autoantibodies directed against glutamic acid decar-
boxylase (GAD) (Solimena et al., 1988, 1990), the cyto-Stiff-Man syndrome (SMS) is a rare disease of the
solic enzyme that synthesizes the inhibitory neurotrans-central nervous system (CNS) characterized by chronic
mitter GABA in the nerve endings of GABA-secretingrigidity, spasms, and autoimmunity directed against
neurons (Erlander and Tobin, 1991). This finding sup-synaptic antigens, most often the GABA-synthesizing
ports the hypothesis that SMS results from an impair-enzyme glutamic acid decarboxylase (GAD). In a sub-
ment of GABAergic transmission. Patients positive forset of cases, SMS has an autoimmune paraneoplastic
anti-GAD autoantibodies represent an autoimmunity-origin. We report here the identification of high-titer
prone population, as they frequently suffer from otherautoantibodies directed against gephyrin in a patient
organ-specific autoimmune diseases, most frequentlywith clinical features of SMS and mediastinal cancer.
type I diabetes (Solimena et al., 1990, 1995). Notably,Gephyrin is a cytosolic protein selectively concen-
pancreatic b cells, the targets of autoimmunity in typetrated at the postsynaptic membrane of inhibitory syn-
I diabetes, are among the few cell types outside theapses, where it is associated with GABAA and glycine CNS expressing detectable levels of GAD (Reetz et al.,receptors. Our findings provide new evidence for a close
1991). Furthermore, anti-GAD autoantibodies are found
link between autoimmunity directed against compo-
in the majority of pre- and newly diagnosed diabetic
nents of inhibitory synapses and neurological condi- subjects, albeit with lower titer than in patients with SMS
tions characterized by chronic rigidity and spasms. (Baekkeskov et al., 1990; Solimena and De Camilli, 1991;
Verge et al., 1998).
Introduction In z5% of patients, SMS is associated with cancer,
generally breast cancer, and these patients typically are
Paraneoplastic neurological syndromes include a vari- positive for autoantibodies directed against amphi-
ety of disorders of the peripheral (PNS) or the central physin I (De Camilli et al., 1993; Folli et al., 1993; Floyd
(CNS) nervous system that occur in association with et al., 1998). Amphiphysin I is a cytosolic presynaptic
cancer but are not the result of metastasis or tumor protein that is widely distributed at synapses, including
compression (Dalmau and Posner, 1999; Darnell, 1999). inhibitory synapses (Lichte et al., 1992; David et al., 1996;
There is increasing evidence that many of these disor- Wigge and McMahon, 1998; Takei et al., 1999). This
ders, including paraneoplastic Stiff-Man syndrome (SMS), protein is present at only very low concentration in other
are associated with autoimmunity against neuronal anti- tissues but is often overexpressed in breast cancer cells
(Floyd et al., 1998). Strikingly, removal of the cancergens. The prevalent hypothesis is that cancer tissues
and immunotherapy are accompanied by a significant
improvement of the neurological symptoms (Folli et al.,
1993; David et al., 1994), suggesting that in these pa-7 To whom correspondence should be addressed (e-mail: pietro.
decamilli@yale.edu [P. D. C.], michele.solimena@yale.edu [M. S.]). tients, SMS has a paraneoplastic origin.
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Figure 1. Autoantibodies of SMS Patient 861
React with Inhibitory Synapses of the CNS
Confocal microscopy of motoneurons in sec-
tions of the rat brainstem labeled with the
serum (top left panel) or the CSF (bottom left
panel) of SMS patient 861. Sections were
double immunostained with a mouse anti-
synaptobrevin II antibody (bottom middle
panel)Ða marker of a subpopulation of pre-
synaptic terminalsÐor a mouse monoclonal
anti-gephyrin antibody (top middle panel).
The antigen recognized by the patient's auto-
antibodies is enriched in a subpopulation of
synapses on the soma of large motoneurons.
We report here the case of a patient with clinical fea- history of illness, including diabetes mellitus, and the
tures of SMS, mediastinic cancer and autoantibodies family history was unremarkable. On neurological exam-
against gephyrin. ination, there was muscle stiffness of the neck, trunk,
shoulders, and legs. Muscle cramps that disappeared
Results during sleep were present on the left half of the face
and in both legs. Stiffness of the tongue muscles was
Clinical Findings associated with slow movements of the tongue, as well
A 58-year-old male (patient 861 of our caseload) was as dysarthria and dysphagia with no abnormal pharyn-
admitted in June of 1998 with a 2 month history of pro- geal reflex, and alterations of the esophagus by endo-
gressive gait disturbance, dysarthria, and dysphagia scopic examination. Ocular movements were normal,
due to muscle stiffness and spasms. There was no past and opsoclonus was absent. Spasms occurred sponta-
neously or were precipitated by active and passive
movements, acoustic stimulation, or touch. Presence of
the spasms prevented the examination of jaw jerk and
deep tendon reflexes in the legs. A reflex myoclonus
associated with tonic spasms in the leg was elicited by
cutaneous stimulation of the foot. Likewise, a startle
response, such as head retraction reflex, was triggered
by cutaneous stimulation of the face. Sensory functions
were normal. Electromyography showed a low-firing fre-
quency of normal units at rest. Renshaw's recurrent
inhibition could not be estimated because the ratio be-
tween the H and the M waves (Kimura, 1989) was very
low on his soleus. Brain, cervical, and lumbar MRIs were
also normal. Routine laboratory investigations were nor-
mal, with the exception of the presence of anti-nuclear
antibody (speckled type, 1:160) and of the tumor marker
NCC-ST 439 (28.9 U/ml; normal range, ,4.5 U/ml). No
abnormalities in cell count, protein, or IgG levels were
found in the cerebrospinal fluid (CSF). Gallium scintigra-Figure 2. Autoantibodies of SMS Patient 861 Recognize Gephyrin
in Rodent Tissues phy and chest CT revealed a mass in the mediastinum,
while additional investigations were negative for the(A) Postnuclear supernatant of rat brain homogenates immunoblot-
ted with either the serum 861 or a control human serum. Serum 861 presence of metastasis elsewhere. Oral diazepam was
reacts with a z97 kDa protein doublet. initiated before surgery (20 mg/day). Both the stiffness
(B) Immunoprecipitation from Triton X-100 extracts of rat brain post-
and spasms lessened markedly, and the patient wasnuclear supernatants with either serum 861 (lane 2) or a control
able to walk and speak smoothly. After the removal ofhuman serum (lane 3) followed by Western blotting with an anti-
gephyrin antibody. An aliquot of the starting material for immunopre- the mediastinal cancer, his symptoms further improved,
cipitation was loaded in lane 1. Serum 861, but not the control serum, and the patient was discharged. Histological investiga-
immunoprecipitates gephyrin. An asterisk indicates an unrelated tion of the mediastinal tumor demonstrated an undiffer-
protein.
entiated carcinoma of undetermined origin. A detailed(C) Western blotting on total spinal cord homogenates from hetero-
clinical report of this patient has been reported else-zygous (1/2) or homozygous (2/2) gephyrin null mice with an anti-
gephyrin antibody or serum 861. where (Harada et al., 1999).
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Figure 5. Mixed GABA/Glycine Synapses as the Putative Targets
of Autoimmunity in SMS
Red stars indicate pre- and postsynaptic autoantigens of SMS. Ab-
breviations: GAD, glutamic acid decarboxylase; GABAT, GABA
Figure 3. Autoantibodies of SMS Patient 861 Recognize Human transporter; GABA-R, GABA receptor; GLYT, glycine transporter;
Gephyrin in Transfected Fibroblasts GlyR, glycine receptor; VGAT, vesicular GABA/glycine carrier.
Double immunofluorescence and confocal microscopy of CHO cells
transiently transfected with human gephyrin cDNA. Cells were im-
When tested against mammalian brain extracts bymunostained either with the serum of patient 861 (A) or with a control
serum (C), and with a monoclonal antibody directed against gephyrin Western blotting, the autoantibodies of the patient did
(B and D). not react with GAD or amphiphysin I but selectively
recognized a protein doublet with an apparent electro-
phoretic mobility of z97 kDa, i.e., the same molecularAutoantibodies to Gephyrin
weight as gephyrin (Figure 2A). In addition, the z97Evidence of autoimmunity in previous cases of SMS
kDa autoantigen immunoprecipitated by the patient'sprompted the search for autoantibodies against neu-
autoantibodies comigrated with gephyrin and was rec-ronal antigens in this patient. Indirect immunocytochem-
ognized by an anti-gephyrin antibody (Figure 2B). Theistry on sections of brain and spinal cord using the serum
97 kDa autoantigen was absent in brain extracts fromof the patient as the source of primary antibodies re-
gephyrin knockout mice (Feng et al., 1998) (Figure 2C).vealed the presence of autoantibodies that specifically
Finally, the patient autoantibodies selectively labeledrecognized a subset of synapses (Figure 1, bottom row).
CHO cells transiently transfected with the cDNA of hu-An identical immunostaining was obtained when the pa-
man gephyrin but not the surrounding, untransfectedtient's CSF was used in place of the serum (Figure 1,
CHO cells (Figures 3A and 3B). On the contrary, nobottom row, left panel). The staining pattern was clearly
staining was present in gephyrin-transfected CHO cellsdistinct from that produced by antibodies directed
incubated with the serum of a control subject (Fig-against GAD or amphiphysin I but was highly suggestive
ures 3C and 3D). Taken together, these results conclu-of inhibitory synapses. It was therefore compared with
sively prove that the serum and the CSF of the patientthe staining produced by antibodies directed against
contained high-titer autoantibodies directed againstgephyrin, a postsynaptic cytoplasmic protein associ-
gephyrin.ated with receptors for the inhibitory neurotransmitters
Neuronal autoantigens of paraneoplastic disordersglycine and GABA (Prior et al., 1992; Kirsch et al., 1993;
are often detected in the cancer tissue (Furneaux et al.,Betz, 1998) (Figure 1, top row). The two staining patterns
1990), supporting the autoimmune origin of the neuro-were identical, pointing to gephyrin as the putative au-
logical symptoms. Western blotting of the patient's me-toantigen.
diastinal tumor with a monoclonal antibody directed
against gephyrin detected a 97 kDa protein with an elec-
trophoretic mobility identical to that of the gephyrin
band present in human and rat brain (Figure 4). Thus,
gephyrin was expressed in the patient's cancer.
The detection of autoantibodies against gephyrin in
this patient is of considerable interest, considering that
exaggerated muscle rigidity in response to sensorial or
Figure 4. The Tumor Tissue of SMS Patient 861 Expresses Gephyrin
emotional stimuli, i.e., a common characteristic of SMS
Protein extract from the tumor tissue of patient 861 (100 mg, lane and a clinical feature of this patient, is present both
1), human brain (10 mg, lane 2), and rat brain (5 mg, lane 3) were
in gephyrin knockout mice (Feng et al., 1998) and inimmunoblotted with a monoclonal antibody directed against geph-
hereditary hyperekplexia (Shiang et al., 1993; Saul et al.,yrin. The gephyrin antibody recognizes a band of identical mobility
in the tumor tissue and in human and rat brain. 1999). Hereditary hyperekplexia is a genetic disorder
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associated with mutations in the glycine receptor, a 2000). Thus, autoantibodies directed against as yet un-
known surface antigens may coexist with antibodies tomain binding partner of gephyrin. This disease, also
known as stiff-baby syndrome or startle syndrome, is dominant cytosolic antigens in the serum of patients
with paraneoplastic neurological syndromes of the CNScharacterized by the presence at birth of hypertonia,
exaggerated startle reflex, and pronounced brainstem but not be easily detectable in the assays routinely used
for autoantibody screening. These autoantibodies couldreflexes, including head retraction reflex (Kok and Bruyn,
1962; Andrew and Owen, 1997). The muscle stiffness be generated by the spread of an autoimmune response
against macromolecular complexes, including both sur-usually recedes during the first year of life, but marked
startle reflex, sometimes accompanied by transient hy- face antigens and associated intracellular proteins (Vin-
cent et al., 1999; Whitney and McNamara, 1999).pertonia, can persist throughout adult life. Similar to
patients with hyperekplexia, our patient had a pro- In conclusion, the precise role of autoantibodies to
cytosolic neuronal proteins in the pathogenesis of auto-nounced head retraction reflex. Notably, some cases of
hyperekplexia had originally been reported as congeni- immune neurological diseases deserves further investi-
gation. However, the identification of gephyrin as thetal forms of SMS (Sander et al., 1980). A close relation-
ship between these two disorders is further suggested autoantigen of an autoimmune CNS disorder whose clin-
ical presentation resembles that of humans and miceby the observation that, in addition to GABA, glycine
neurotransmission may also be affected in SMS (Floeter with genetic alteration of inhibitory synapses adds new
evidence to the hypothesis that the autoantibodies ofet al., 1998).
SMS patients are closely linked to pathogenic mecha-
nisms.Discussion
Experimental ProceduresOur data indicate that patients with clinical features of
SMS can have autoantibodies directed against either
Antibodies
pre- or postsynaptic components of inhibitory synapses The serum and CSF of patient 861 and healthy control subjects
(Figure 5). Spinal cord interneurons that control moto- were collected after informed consent and stored at 2208C until
neuron activity have been shown to cosecrete both used. A mouse monoclonal antibody directed against synaptobrevin
II was kindly provided by Dr. R. Jahn (Goettingen, Germany). AGABA and glycine (Jonas et al., 1998). We suggest that
mouse monoclonal antibody directed against gephyrin was pur-these mixed GABA/glycine synapses are the primary
chased from Transduction Laboratories (Lexington, KY). Cy3-conju-targets of autoimmunity in SMS. The postsynaptic hy-
gated goat anti-human IgG (Jackson Immunoresearch, West Grove,
perpolarization associated with the activation of GABAA PA) or Alexa488-conjugated goat anti-mouse IgG (Molecular
receptors is slower but more prolonged than the inhibi- Probes, Eugene, OR) was used for immunocytochemistry at a dilu-
tion mediated by glycine receptors (Jonas et al., 1998). tion of 1:50 or 1:100, respectively.
Thus, the relative prevalence of chronic rigidity or startle
Cell Transfection and Immunocytochemistryresponses in different SMS patients may be attributed
The full-length cDNA of human gephyrin (Z. Nikolic, C. Villman, C.-M.to the variable degree of involvement of GABA or glycine
Becker) was subcloned as a ClaI-PstI insert into the mammalian
neurotransmission. expression vector pRK5. Transient transfection and immunostaining
The pathogenesis of paraneoplastic neurological syn- of CHO cells were performed as previously described (Dirkx et al.,
dromes of the CNS is still unclear. Each of these condi- 1995). Indirect immunofluorescence staining on frozen sections of
paraformaldehyde-fixed rat brain and spinal cord was performedtions is accompanied by the presence of high-titer auto-
as previously described (De Camilli et al., 1983). For the staining ofantibodies directed against one or a few intracellular
gephyrin-transfected CHO cells, the serum of patient 861 and theantigens shared by neurons and cancer cells, such as
control serum were used at a dilution of 1:100. For the staining of
gephyrin in the patient described here. The question rat brain sections, the serum and CSF of patient 861 and control
remains as to how autoantibodies arise and whether human sera were used at dilutions of 1:8 and 1:2, respectively. The
and how these autoantibodies can gain access to the monoclonal antibodies against gephyrin or synaptobrevin were used
at a dilution of 1:100. Confocal microscopy was performed using acytosolic compartment of neurons and perturb the activ-
BioRad MRC 1024 (Bio-Rad, Hercules, CA).ity of their target antigens (Vincent et al., 1999; Whitney
and McNamara, 1999). Alternatively, T cells or other
Western Blottingassociated antibodies directed against surface antigens
Postnuclear supernatants from rat brain and spinal cord of
may mediate the disease. There is evidence that T cell± gephyrin1/2 and gephyrin2/2 mice were prepared as previously de-
mediated cytotoxicity, rather than humoral autoimmu- scribed (Reetz et al., 1991; Feng et al., 1998). Protein (100 mg) was
loaded in each lane, separated by SDS gel electrophoresis, andnity, mediates Purkinje cell death in the paraneoplastic
then transferred onto nitrocellulose. For Western blotting, humancerebellar degeneration associated with anti-cdr2 auto-
sera and anti-gephyrin antibody were used at dilutions of 1:1000antibodies (Albert et al., 1998). A variety of paraneoplas-
and 1:200, respectively. Mouse and human IgG were detected withtic syndromes affecting the neuromuscular junction,
rabbit anti-mouse or rabbit anti-human IgG followed by 125I-protein
such as myasthenia gravis, Lambert-Eaton myasthenic A (Solimena et al., 1990).
syndrome, and Isaac's syndrome (Drachman, 1994; Len- Tumor tissue from SMS patient 861 was pulverized under liquid
nitrogen and resuspended (4 ml/mg tissue) in 150 mM NaCl, 10 mMnon et al., 1995; Newsom-Davis, 1999), are caused by
HEPES (pH 7.5) containing a protease inhibitor cocktail (Complete,autoantibodies against surface antigens. At least two
Roche, Indianapolis, IN). Next, the tissue powder was homogenizeddisorders of the CNS, Rasmussen's encephalitis and
using a motorized pellet pestle and centrifuged at 600 3 g. Theparaneoplastic cerebellar ataxia, can apparently be me-
pellet was discarded, and the supernatant was analyzed for protein
diated by autoantibodies directed against the glutamate content with the BCA assay (Pierce, Rockford, IL). Extracts from
receptor 3 or the metabotrobic glutamate receptor 1, human brain in sample buffer (10 mg/ml) were purchased from Clon-
tech (Palo Alto, CA). Protein from the tumor tissue and from humanrespectively (Rogers et al., 1994; Sillevis Smitt et al.,
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and rat brain was separated by SDS gel electrophoresis and immu- Drachman, D.B. (1994). Myasthenia gravis. N. Engl. J. Med. 330,
1797±1810.noblotted with the anti-gephyrin antibody followed by peroxidase-
conjugated goat anti-mouse IgG and Supersignal chemilumines- Erlander, M.G., and Tobin, A.J. (1991). The structural and functional
cence reagent (Pierce). heterogeneity of glutamic acid decarboxylase: a review. Neuro-
chem. Res. 16, 215±226.
Immunoprecipitation Feng, G., Tintrup, H., Kirsch, J., Nichol, M.C., Kuhse, J., Betz, H.,
Immunoprecipitation with human sera from Triton X-100 rat brain and Sanes, J.R. (1998). Dual requirement for gephyrin in glycine
extracts was performed as previously described (De Camilli et al., receptor clustering and molybdoenzyme activity. Science 282,
1993). Immunoprecipites were separated by SDS gel electrophore- 1321±1324.
sis and immunoblotted with the anti-gephyrin antibody as described Floeter, M.K., Valls-Sole, J., Toro, C., Jacobowitz, D., and Hallett,
above. M. (1998). Physiologic studies of spinal inhibitory circuits in patients
with stiff-person syndrome. Neurology 51, 85±93.
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